BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2155588)

  • 21. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
    Pujol JL; Carestia L; Daurès JP
    Br J Cancer; 2000 Jul; 83(1):8-15. PubMed ID: 10883661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
    Fan Y; Huang ZY; Zhang YP; Sun L
    Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of acute myocardial infarction after treatment with cisplatin].
    Sasaki M; Suzuki A; Ishihara T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2289-91. PubMed ID: 2735771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H; Bando H; Takishita Y
    Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
    Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N
    Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
    Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
    Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myocardial infarction during a treatment combining etoposide and cisplatin].
    Caron F; Valy Y; Meurice JC; Perault MC; Patte F
    Presse Med; 1997 Nov; 26(35):1674. PubMed ID: 9452745
    [No Abstract]   [Full Text] [Related]  

  • 29. A rare case of cisplatin-induced acute myocardial infarction in a patient receiving chemoradiation for lung cancer.
    Rao AS; Kumar R; Narayanan GS
    J Cancer Res Ther; 2015; 11(4):983-5. PubMed ID: 26881563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
    Madrigal PA; Manga GP; Palomero I; Gomez RG
    Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isolated right ventricular myocardial infarction and saccular focal aortic root dissection leading to right coronary artery ostial obstruction in a patient receiving chemotherapy for small cell lung cancer].
    Yildiz A; Eren F; Olcay A; Erol C
    Turk Kardiyol Dern Ars; 2010 Apr; 38(3):224. PubMed ID: 20676006
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination cis-platinum and etoposide in small-cell lung cancer.
    Natale RB; Wittes RE
    Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
    [No Abstract]   [Full Text] [Related]  

  • 33. Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis.
    Escoto H; Ringewald J; Kalpatthi R
    Cardiol Young; 2010 Feb; 20(1):105-7. PubMed ID: 20181298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute arterial thrombosis in a patient with small cell lung cancer after a cycle of chemotherapy with cisplatin and etoposide.
    Longo F; Mansueto G; Poggi A; Pellegrini P; Falzetta A; Rozzi A; Marchei P
    Tumori; 1999; 85(3):214-5. PubMed ID: 10426136
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrocardiographic changes simulating acute myocardial infarction or ischemia associated with combination chemotherapy with etoposide, cisplatin, and 5-fluorouracil.
    Lee KH; Lee JS; Kim SH
    Korean J Intern Med; 1990 Jul; 5(2):112-7. PubMed ID: 2098095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasospastic angina likely related to cisplatin-containing chemotherapy and thoracic irradiation for lung cancer.
    Fukuda M; Oka M; Itoh N; Sakamoto T; Mori H; Hayakawa A; Kohno S
    Intern Med; 1999 May; 38(5):436-8. PubMed ID: 10397083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: cisplatin-induced hemolytic uremic syndrome.
    Khansur T; Kennedy A
    Am J Med Sci; 1991 Jun; 301(6):390-2. PubMed ID: 1645502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal pulmonary toxicity following oral etoposide therapy.
    Dajczman E; Srolovitz H; Kreisman H; Frank H
    Lung Cancer; 1995 Mar; 12(1-2):81-6. PubMed ID: 7600034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etoposide-related myocardial infarction.
    Airey CL; Dodwell DJ; Joffe JK; Jones WG
    Clin Oncol (R Coll Radiol); 1995; 7(2):135. PubMed ID: 7619765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Bilateral Renal and Splenic Infarctions Occurring during Chemotherapy for Lung Cancer.
    Koyama N; Tomoda K; Matsuda M; Fujita Y; Yamamoto Y; Hontsu S; Tasaki M; Yoshikawa M; Kimura H
    Intern Med; 2016; 55(24):3635-3639. PubMed ID: 27980265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.